JHS Svendgaard Laboratories Limited (JHS.BO)
INR 22.23
(0.0%)
INR 22.23
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -40.57 Million INR | 73.76% |
| 2022 | -154.63 Million INR | -281.63% |
| 2021 | -40.52 Million INR | -438.17% |
| 2020 | 11.98 Million INR | 160.54% |
| 2019 | -19.79 Million INR | -190.79% |
| 2018 | -6.8 Million INR | -102.6% |
| 2017 | 261.49 Million INR | 19.2% |
| 2016 | 219.36 Million INR | 201.37% |
| 2015 | -216.41 Million INR | 2.42% |
| 2014 | -221.76 Million INR | 23.02% |
| 2013 | -288.09 Million INR | -665.94% |
| 2012 | -37.61 Million INR | -439.35% |
| 2011 | 11.08 Million INR | -90.92% |
| 2010 | 122.09 Million INR | 52.16% |
| 2009 | 80.24 Million INR | 480.05% |
| 2008 | 13.83 Million INR | -61.05% |
| 2007 | 35.51 Million INR | -18.79% |
| 2006 | 43.73 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -6.29 Million INR | 16.33% |
| 2023 Q2 | -7.29 Million INR | 73.34% |
| 2023 Q1 | -27.37 Million INR | 72.27% |
| 2023 FY | -40.57 Million INR | 73.76% |
| 2023 Q4 | -7.51 Million INR | -6067.46% |
| 2023 Q3 | 126 Thousand INR | 101.73% |
| 2022 FY | -154.63 Million INR | -281.63% |
| 2022 Q1 | -38.45 Million INR | 11.76% |
| 2022 Q2 | -9.15 Million INR | 76.19% |
| 2022 Q3 | -15.28 Million INR | -66.91% |
| 2022 Q4 | -98.74 Million INR | -546.12% |
| 2021 Q3 | 2.65 Million INR | -0.26% |
| 2021 Q2 | 2.65 Million INR | 217.97% |
| 2021 FY | -40.52 Million INR | -438.17% |
| 2021 Q1 | -2.25 Million INR | -108.57% |
| 2021 Q4 | -43.57 Million INR | -1743.17% |
| 2020 Q2 | 9.78 Million INR | 138.83% |
| 2020 Q1 | -25.18 Million INR | -38.73% |
| 2020 FY | 11.98 Million INR | 160.54% |
| 2020 Q4 | 26.31 Million INR | 2340.82% |
| 2020 Q3 | 1.07 Million INR | -88.98% |
| 2019 FY | -19.79 Million INR | -190.79% |
| 2019 Q1 | -2.87 Million INR | -117.98% |
| 2019 Q2 | -5.44 Million INR | -89.63% |
| 2019 Q4 | -18.15 Million INR | -371.43% |
| 2019 Q3 | 6.68 Million INR | 222.78% |
| 2018 Q4 | -1.31 Million INR | -115.66% |
| 2018 Q1 | -4.61 Million INR | -116.2% |
| 2018 FY | -6.8 Million INR | -102.6% |
| 2018 Q3 | 8.41 Million INR | 190.56% |
| 2018 Q2 | -9.29 Million INR | -101.61% |
| 2017 Q3 | 25.15 Million INR | 41.93% |
| 2017 FY | 261.49 Million INR | 19.2% |
| 2017 Q4 | 28.45 Million INR | 13.12% |
| 2017 Q2 | 17.72 Million INR | -90.68% |
| 2017 Q1 | 190.16 Million INR | 2.52% |
| 2016 FY | 219.36 Million INR | 201.37% |
| 2016 Q4 | 185.49 Million INR | 959.61% |
| 2016 Q1 | 3.05 Million INR | 101.73% |
| 2016 Q2 | 13.39 Million INR | 338.51% |
| 2016 Q3 | 17.5 Million INR | 30.72% |
| 2015 Q1 | -15.29 Million INR | 83.01% |
| 2015 FY | -216.41 Million INR | 2.42% |
| 2015 Q4 | -176.39 Million INR | -1038.89% |
| 2015 Q2 | -9.23 Million INR | 39.62% |
| 2015 Q3 | -15.48 Million INR | -67.69% |
| 2014 Q3 | -34.53 Million INR | 24.5% |
| 2014 Q1 | -51.43 Million INR | -10.53% |
| 2014 FY | -221.76 Million INR | 23.02% |
| 2014 Q4 | -90.03 Million INR | -160.73% |
| 2014 Q2 | -45.73 Million INR | 11.08% |
| 2013 Q3 | -79.97 Million INR | 13.42% |
| 2013 FY | -288.09 Million INR | -665.94% |
| 2013 Q1 | -69.21 Million INR | -340.66% |
| 2013 Q2 | -92.37 Million INR | -33.46% |
| 2013 Q4 | -46.53 Million INR | 41.81% |
| 2012 Q1 | 43.54 Million INR | 0.0% |
| 2012 Q4 | -15.7 Million INR | 68.46% |
| 2012 Q2 | -15.64 Million INR | -135.93% |
| 2012 Q3 | -49.8 Million INR | -218.32% |
| 2012 FY | -37.61 Million INR | -439.35% |
| 2011 FY | 11.08 Million INR | -90.92% |
| 2010 FY | 122.09 Million INR | 52.16% |
| 2009 FY | 80.24 Million INR | 480.05% |
| 2008 FY | 13.83 Million INR | -61.05% |
| 2007 FY | 35.51 Million INR | -18.79% |
| 2006 FY | 43.73 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Ador Multiproducts Limited | -40.2 Million INR | -0.931% |
| Ambica Agarbathies Aroma & Industries Limited | -36.62 Million INR | -10.8% |
| Bajaj Consumer Care Limited | 1.55 Billion INR | 102.611% |
| Colgate-Palmolive (India) Limited | 13.23 Billion INR | 100.307% |
| Cupid Limited | 398.54 Million INR | 110.181% |
| Dabur India Limited | 18.42 Billion INR | 100.22% |
| Emami Limited | 7.23 Billion INR | 100.561% |
| Gillette India Limited | 4.11 Billion INR | 100.986% |
| Godrej Consumer Products Limited | -5.6 Billion INR | 99.276% |
| Hindustan Unilever Limited | 102.77 Billion INR | 100.039% |
| Hipolin Limited | -8.86 Million INR | -357.928% |
| Honasa Consumer Limited | 1.11 Billion INR | 103.63% |
| Jyothy Labs Limited | 3.69 Billion INR | 101.098% |
| Kaya Limited | -1.29 Billion INR | 96.86% |
| Marico Limited | 14.81 Billion INR | 100.274% |
| N.K Industries Limited | -10.3 Million INR | -293.799% |
| PAOS INDUSTRIES LIMITED | -2.95 Million INR | -1271.308% |
| Paramount Cosmetics (India) Limited | 214 Thousand INR | 19061.215% |
| Pee Cee Cosma Sope Limited | 104.43 Million INR | 138.853% |
| Procter & Gamble Hygiene and Health Care Limited | 6.75 Billion INR | 100.601% |